b)

įrašai, atitinkantys indekso numerius 006–035–00–8, 029–002–00-X, 602–020–00–0, 602–033–00–1, 603–055–00–4, 604–030–00–0, 604–092–00–9, 605–013–00–0, 605–022–00-X, 606–014–00–9, 606–021–00–7, 607–056–00–0, 607–059–00–7, 607–157–00-X, 607–172–00–1, 607–375–00–5, 607–623–00–2, 613–166–00-X, 613–121–00–4, 616–011–00–4, 616–037–00–6 ir 616–207–00-X, pakeičiami šiais atitinkamais įrašais: Indekso Nr. Tarptautinė cheminė identifikacija EB Nr. CAS Nr. Klasifikacija Ženklinimas Konkrečios ribinės koncentracijos, M faktoriai Pastabos Pavojingumo klasės ir kategorijos kodas (-ai) Pavojingumo frazės kodas (-ai) Piktogramos, signalinio žodžio kodas (-ai) Pavojingumo frazės kodas (-ai) Papildomas (-i) pavojingumo frazės kodas (-ai) „006–035–00–8 pirimikarbas (ISO); 2-(dimetilamin)-5,6-dimetilpirimidin-4-il dimetilkarbamatas 245–430–1 23103–98–2 Carc. 2 Acute Tox. 3 Acute Tox. 3 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H351 H331 H301 H317 H400 H410 GHS08 GHS06 GHS09 Dgr H351 H331 H301 H317 H410 M = 10 M = 100“ „029–002–00-X divario oksidas; vario (I) oksidas 215–270–7 1317–39–1 Acute Tox. 4 Acute Tox. 4 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H332 H302 H318 H400 H410 GHS07 GHS05 GHS09 Dgr H332 H302 H318 H410 M = 100“ „602–020–00–0 1,2-dichlorpropanas; propilendichloridas 201–152–2 78–87–5 Flam. Liq. 2 Carc. 1B Acute Tox. 4* Acute Tox. 4* H225 H350 H332 H302 GHS02 GHS08 GHS07 Dgr H225 H350 H332 H302“ „602–033–00–1 chlorbenzenas 203–628–5 108–90–7 Flam. Liq. 3 Acute Tox. 4 Skin Irrit. 2 Aquatic Chronic 2 H226 H332 H315 H411 GHS02 GHS07 GHS09 Wng H226 H332 H315 H411“ „603–055–00–4 propilenoksidas; 1,2-epoksipropanas; metiloksiranas 200–879–2 75–56–9 Flam. Liq. 1 Carc. 1B Muta. 1B Acute Tox. 3 Acute Tox. 3 Acute Tox. 4 STOT SE 3 Eye Irrit. 2 H224 H350 H340 H331 H311 H302 H335 H319 GHS02 GHS08 GHS06 Dgr H224 H350 H340 H331 H311 H302 H335 H319“ „604–030–00–0 bisfenolis A; 4,4′-izopropilidendifenolis 201–245–8 80–05–7 Repr. 1B STOT SE 3 Eye Dam. 1 Skin Sens. 1 H360F H335 H318 H317 GHS08 GHS05 GHS07 Dgr H360F H335 H318 H317“ „604–092–00–9 fenolis, dodecil-, šakotasis; [1] fenolis, 2-dodecil-, šakotasis; [2] fenolis, 3-dodecil-, šakotasis; [3] fenolis, 4-dodecil-, šakotasis; [4] fenolis, (tetrapropenilo) dariniai [5] 310–154–3 [1] [2] [3] [4] [5] 121158–58–5 [1] [2] [3] 210555–94–5 [4] 74499–35–7 [5] Repr. 1B Skin Corr. 1C Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H360F H314 H318 H400 H410 GHS08 GHS05 GHS09 Dgr H360F H314 H410 M = 10 M = 10“ „605–013–00–0 chloralozė (INN); (R)-1,2-O-(2,2,2-trichloretiliden)-α-D-gliukofuranozė; gliukochloralozė; anhidrogliukochloralis 240–016–7 15879–93–3 Acute Tox. 4* Acute Tox. 3 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 H332 H301 H336 H400 H410 GHS06 GHS09 Dgr H332 H301 H336 H410 M = 10 M = 10 C“ „605–022–00-X glutaralis; glutaraldehidas; 1,5-pentandialis 203–856–5 111–30–8 Acute Tox. 2 Acute Tox. 3 STOT SE 3 Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1A Aquatic Acute 1 Aquatic Chronic 2 H330 H301 H335 H314 H334 H317 H400 H411 GHS06 GHS05 GHS08 GHS09 Dgr H330 H301 H335 H314 H334 H317 H410 EUH071 STOT SE 3; H335: 0,5 % ≤ C < 5 % M = 1“ „606–014–00–9 chlorfacinonas (ISO); 2-[(4-chlorfenil)(fenil)acetil]-1H-inden-1,3(2H)-dionas 223–003–0 3691–35–8 Repr. 1B Acute Tox. 1 Acute Tox. 1 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 H360D H330 H310 H300 H372 (kraujas) H400 H410 GHS08 GHS06 GHS09 Dgr H360D H330 H310 H300 H372 (kraujas) H410 Repr. 1B; H360D: C ≥ 0,003 % STOT RE 1; H372 (kraujas): C ≥ 0,1 % STOT RE 2; H373 (kraujas): 0,01 % ≤ C < 0,1 % M = 1 M = 1“ „606–021–00–7 N-metil-2-pirolidonas; 1-metil-2-pirolidonas 212–828–1 872–50–4 Repr. 1B STOT SE 3 Skin Irrit. 2 Eye Irrit. 2 H360D*** H335 H315 H319 GHS08 GHS07 Dgr H360D*** H335 H315 H319 STOT SE 3; H335: C ≥ 10 %“ „607–056–00–0 varfarinas (ISO); 4-hidroksi-3-(3-okso-1-fenilbutil)-2H-chromen-2-onas; [1] (S)-4-hikdroksi-3-(3-okso-1-fenilbutil)-2-benzopironas; [2] (R)-4-hidroksi-3-(3-okso-1-fenilbutil)-2-benzopironas [3] 201–377–6 [1] 226–907–3 [2] 226–908–9 [3] 81–81–2 [1] 5543–57–7 [2] 5543–58–8 [3] Repr. 1A Acute Tox. 1 Acute Tox. 1 Acute Tox. 2 STOT RE 1 Aquatic Chronic 2 H360D H330 H310 H300 H372 (kraujas) H411 GHS08 GHS06 GHS09 Dgr H360D H330 H310 H300 H372 (kraujas) H411 Repr. 1A; H360D: C ≥ 0,003 % STOT RE 1; H372 (kraujas): C ≥ 0,5 % STOT RE 2; H373 (kraujas): 0,05 % ≤ C < 0,5 %“ „607–059–00–7 kumatetralilas (ISO); 4-hidroksi-3-(1,2,3,4-tetrahidro-1-naftil)kumarinas 227–424–0 5836–29–3 Repr. 1B Acute Tox. 2 Acute Tox. 3 Acute Tox. 2 STOT RE 1 Aquatic Chronic 1 H360D H330 H311 H300 H372 (kraujas) H410 GHS08 GHS06 GHS09 Dgr H360D H330 H311 H300 H372 (kraujas) H410 Repr. 1B; H360D: C ≥ 0,003 % STOT RE 1; H372 (kraujas): C ≥ 1,0 % STOT RE 2; H373 (kraujas) 0,1 % ≤ C < 1,0 % M = 10“ „607–157–00-X difenakumas (ISO); 3-(3-bifenil-4-il-1,2,3,4-tetrahidro-1-naftil)-4-hidroksikumarinas 259–978–4 56073–07–5 Repr. 1B Acute Tox. 1 Acute Tox. 1 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 H360D H330 H310 H300 H372 (kraujas) H400 H410 GHS08 GHS06 GHS09 Dgr H360D H330 H310 H300 H372 (kraujas) H410 Repr. 1B; H360D: C ≥ 0,003 % STOT RE 1; H372 (kraujas): C ≥ 0,02 % STOT RE 2; H373 (kraujas): 0,002 % ≤ C < 0,02 % M = 10 M = 10“ „607–172–00–1 brodifakumas (ISO); 4-hidroksi-3-(3-(4′-brom-4-bifenilil)-1,2,3,4-tetrahidro-1-naftil)kumarinas 259–980–5 56073–10–0 Repr. 1A Acute Tox. 1 Acute Tox. 1 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 H360D H330 H310 H300 H372 (kraujas) H400 H410 GHS08 GHS06 GHS09 Dgr H360D H330 H310 H300 H372 (kraujas) H410 Repr. 1A; H360D: C ≥ 0,003 % STOT RE 1; H372 (kraujas): C ≥ 0,02 % STOT RE 2; H373 (kraujas): 0,002 % ≤ C < 0,02 % M = 10 M = 10“ „607–375–00–5 flokumafenas (ISO); cis-4-hidroksi-3-(1,2,3,4-tetrahidro-3-(4-(4-trifluormetilbenziloksi)fenil)-1-naftil)kumarino ir trans-4-hidroksi-3-(1,2,3,4-tetrahidro-3-(4-(4-trifluormetilbenziloksi)fenil)-1-naftil)kumarino reakcijos masė 421–960–0 90035–08–8 Repr. 1B Acute Tox. 1 Acute Tox. 1 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 H360D H330 H310 H300 H372 (kraujas) H400 H410 GHS08 GHS06 GHS09 Dgr H360D H330 H310 H300 H372 (kraujas) H410 Repr. 1B; H360D: C ≥ 0,003 % STOT RE 1; H372 (kraujas): C ≥ 0,05 % STOT RE 2; H373 (kraujas): 0,005 % ≤ C < 0,05 % M = 10 M = 10“ „607–623–00–2 diizobutilftalatas 201–553–2 84–69–5 Repr. 1B H360Df GHS08 Dgr H360Df“ „613–166–00-X flumioksazinas (ISO); 2-[7-fluor-3-okso-4-(prop-2-in-1-il)-3,4-dihidro-2H-1,4-benzoksazin-6-il]-4,5,6,7-tetrahidro-1H-izoindol-1,3(2H)-dionas — 103361–09–7 Repr. 1B Aquatic Acute 1 Aquatic Chronic 1 H360D H400 H410 GHS08 GHS09 Dgr H360D H410 M = 1 000 M = 1 000 “ „613–121–00–4 chlorsulfuronas (ISO); 2-chlor-N-[[(4-metoksi-6-metil-1,3,5-triazin-2- il)amin]karbonil]benzensulfonamidas 265–268–5 64902–72–3 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 M = 1 000 M = 100“ „616–011–00–4 N,N-dimetilacetamidas 204–826–4 127–19–5 Repr. 1B Acute Tox. 4* Acute Tox. 4* H360D*** H332 H312 GHS08 GHS07 Dgr H360D*** H332 H312“ „616–037–00–6 acetochloras (ISO); 2-chlor-N-(etoksimetil)-N-(2-etil-6-metilfenil)acetamidas 251–899–3 34256–82–1 Carc. 2 Repr. 2 Acute Tox. 4 STOT SE 3 STOT RE 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H351 H361f H332 H335 H373 (inkstai) H315 H317 H400 H410 GHS08 GHS07 GHS09 Wng H351 H361f H332 H335 H373 (inkstai) H315 H317 H410 M = 1 000 M = 100“ „616–207–00-X poliheksametilenbiguanido hidrochloridas; PHMB — 32289–58–0 27083–27–8 Carc. 2 Acute Tox. 2 Acute Tox. 4 STOT RE 1 Eye Dam. 1 Skin Sens. 1B Aquatic Acute 1 Aquatic Chronic 1 H351 H330 H302 H372 (kvėpavimo takai) (įkvėpus) H318 H317 H400 H410 GHS08 GHS06 GHS05 GHS09 Dgr H351 H330 H302 H372 (kvėpavimo takai) (įkvėpus) H318 H317 H410 M = 10 M = 10“